RELX PLC bought 746,868 of its own shares on the London Stock Exchange from 28 September to 2 October 2026, at an average price of 2503.5372 pence per share

RELX PLC bought 746,868 of its own shares on the London Stock Exchange from 28 September to 2 October 2026, at an average price of 2503.5372 pence per share. The shares will be held as treasury stock. The company now holds 86,076,451 shares in treasury and has 1,743,014,323 shares in issue, excluding treasury shares. Since 2 January 2026, RELX PLC has purchased 81,968,579 ordinary shares.

Original reporting
Published Oct 5, 2026, 1:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 2:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$RELX
Neutral
medium confidence
Mentioned
$RELX
Relevance
5/10
AlphAI data visualization · based on investegate.co.uk
Decision brief

The 30-second read

$RELXNeutralLow
01

Why it matters

The disclosed tranche adds roughly 0.04% to the total shares repurchased year‑to‑date, a routine signal of confidence but unlikely to move the stock significantly on its own.

02

Market read

A modest, routine buyback that may provide slight price support but is unlikely to be a primary driver of market moves.

03

What to watch

Potential upcoming earnings guidance or macro‑economic data could dominate price action, rendering the buyback impact negligible.

Relevance 5/10Novelty 5/10Timing: today

Background

RELX is a leading global provider of information and analytics services, regularly conducting share repurchases as part of its capital allocation strategy.

Company-level read

Ticker impact

$RELXNeutralMedium confidence
Context

RELX disclosed a buyback of 746,868 shares at an average price of 2503.5372 pence, adding to its treasury holdings.

Expected impact

likely slight upward pressure as the market prices in the buyback signal

Evidence & confidence

Buybacks of this size are routine for a large cap; impact is limited but can provide a modest boost.

Market effects

Minimal; other information‑services firms may note the buyback as a standard capital‑return practice.

Limited to UK and European markets where RELX is a major component.

Low; the disclosure does not affect broader market dynamics.

Counterpoint

The buyback may be a defensive move to support the stock amid broader market weakness, offering a short‑term entry point.

Key entities

  • RELX PLC

    Global information and analytics provider executing a share buyback.

  • J.P. Morgan Securities plc

    Broker facilitating the share repurchase.

Related articles

$RELXMed

RELX Presents Strategy to Accelerate STM Revenue Growth

RELX reported 6% underlying revenue growth in its Scientific, Technical & Medical business for H1 2026, with adjusted operating profit up 8%. The segment contributed 28% of group revenue and 30% of profit. Elsevier saw a 20% rise in article submissions and 7% increase in published articles. The company aims to boost research publishing and product innovation to maintain profit growth ahead of revenue.

$RELXMed

Why is Relx stock climbing today?

Relx PLC ADR stock rose 1.2% in pre-market trading after reporting 7% underlying revenue growth for the nine-month period, with its Legal division leading at 10%. The company also announced a £125M share buyback. The update met investor expectations and maintained full-year targets. The stock's gain contrasts with broader market declines.

$RELXHighAI 8/10

Relx reports 7% underlying revenue growth, reaffirms full-year outlook

Relx reported 7% underlying revenue growth for the first nine months of 2026, driven by AI-powered analytics tools. The company reaffirmed its full-year outlook, expecting strong revenue and profit growth. Legal, Risk, and Scientific divisions led growth, while Exhibitions faced Middle East disruptions. Relx anticipates adjusted operating profit to grow faster than revenue in most divisions.

$RELXMed

Relx Q3 Earnings Call Highlights

Relx (RELX) reported Q3 earnings, with Legal division revenue growing 10% and STM division up 6%. Lexis+ Protégé platform adoption is over 50% in the U.S. LeapSpace, an AI workspace, saw user base double in 90 days. Exhibitions growth was impacted by Middle East disruption. Relx plans to discuss STM growth and AI initiatives in November.

$RELXHighAI 8/10

Relx defies AI disruption fears as growth holds firm

Relx reported a 7% rise in underlying revenue for the first nine months of 2026, with all divisions growing. Legal business saw the highest growth at 10%, driven by AI-powered research tools. The company maintained its full-year forecast for revenue, profit, and earnings per share. Relx argues its specialist data gives it an advantage over AI competitors. Shares have been volatile amid broader sector sell-offs.